BONE MARROW TRANSPLANTATION

Rivista

Codice:

E024120

ISSN:

0268-3369

Dati Generali

Pubblicazioni (322)

A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study

Articolo

A recent update of 3 consecutive prospective trials with high-dose therapy and autograft, without or with rituximab, as primary treatment for advanced-stage follicular lymphoma shows a sizeable group of patients surviving in continuous complete remission

Abstract

A survey of fully haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia: a study by the Severe Aplastic Anaemia Working Party (SAAWP) and Paediatric Diseases Working Party (PDWP) of the European Blood and Marrow Transplantation Group (EBMT)

Abstract

ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING

Abstract

Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database

Articolo

Adoptive transfer of IL-2 activated T-cells following autologous haematopoietic cell transplantation in patients with breast cancer

Articolo

Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients

Abstract

Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders

Abstract

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Articolo

Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Articolo

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry

Articolo

Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

Articolo

Allogeneic stem cell transplantation following a reduced-intensity conditioning regimen in relapsed lymphomas: 5 year follow-up of the phase II study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Abstract

Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT

Articolo

Allogeneic transplantation from alternative donors is feasible in elderly patients with poor prognosis acute myeloid leukaemia or myelodysplastic syndrome: a single-centre experience

Abstract

Allogeneic transplantation from matched and alternative donors in elderly: results in 28 patients

Abstract

Allogeneic transplantation in elderly patients with poor prognosis acute myeloid leukaemia or myelodysplastic syndrome; the San Raffaele Institute experience

Abstract

Allografting from unrelated donors in multiple myeloma: a study by the Italian bone marrow donor registry

Abstract

Allotransplant after autologous haematopoietic stem cell transplantation relapse in aggressive lymphoma patients: update af a retrospective GITMO study

Abstract

Allotransplant as salvage therapy after autologous haematopoietic stem cell transplantation relapse in diffuse large B cell lymphoma patients: a retrospective GITMO study

Abstract

Alternative donor transplantation in patients with active acute leukemia at transplant (GANDALF): final analysis of a prospective Study from Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Abstract

AmBisome (R) as antifungal primary prophylaxis in patients undergoing allogeneic stem cell transplantation from alternative donor: preliminary results of phase II "Prophessor" trial

Abstract

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT

Abstract

An international survey to better understand the current incidence, severity, and management of VOD/SOS

Articolo

Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation

Abstract

Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience

Abstract

Anti-fungal primary and secondary prophylaxis with liposomal amphotericin B (AmBisome) in patients undergoing family haploidentical allogeneic haematopoietic cell transplantation for high-risk haematologic malignancies

Articolo

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

Articolo

Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders

Abstract

Autologous haematopoietic stem cell transplantation is more effective in relapsing/remitting multiple sclerosis forms

Articolo

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission

Articolo

B- and T-cell interactions in graft-versus-host disease

Poster

BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT

Articolo

Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting

Articolo

Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy

Articolo

Bone marrow mammaglobin express ion as a tool for assessing micrometastatic disease after reduced-intensity allografting for advanced breast cancer

Articolo

Bone marrow morphology and cytogenetics in donors provide additional safety in allogeneic haematopoietic stem cell transplantation: results in 460 healthy candidates

Abstract

Bone-to-bone boost in poor graft function after haploidentical haematopoietic stem cell transplant: safety and feasibility. Two case reports

Abstract

Building and implementing a new paediatric nurse transplant team within an adult BMT unit in a Milan hospital

Abstract

CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide

Articolo

CIITA-DEPENDENT TRANSCRIPTIONAL DOWNREGULATION OF HLA CLASS II RESULTS IN LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER ALLOGENEIC HSCT

Abstract

CMV-specific T Cell Counts Early after Allogeneic Hematopoietic Stem Cell Transplantation Stratify the Risk of Subsequent CMV Reactivations: Results of a Prospective Observational Study

Abstract

COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

Articolo

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

Articolo

Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors

Articolo

Cidofovir treatment for haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation for high risk haematological malignancies

Abstract

Clinical and molecular features associated with acute myeloid leukemia engraftment in immunodeficient mouse models

Abstract

Clinical and molecular remissions can be achieved in advanced leukemias and lymphomas using reduced intensity conditioning followed by allografting of hematopoietc cells

Articolo

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

Articolo

Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation

Articolo

Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients

Articolo

Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients

Articolo

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

Articolo

Comparative evaluation of the predictive power of the EBMT risk score and the Hematopoietic Cell Transplantation Co-morbidity Index for allogeneic haematopoietic stem cell transplantation in a treosulfan-based conditioning setting

Abstract

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

Articolo

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

Articolo

Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Articolo

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Articolo

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group an observational analysis by the Acute Leukemia Working Party of the EBMT

Articolo

Consolidation of complete remission with high-dose chemotherapy and autologous stem cell rescue in AML and high-risk MDS elderly patients: feasibility and preliminary results

Articolo

Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation

Articolo

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (Bone Marrow Transplantation, (2022), 57, 7, (1116-1123), 10.1038/s41409-022-01693-8)

Articolo

Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

Articolo

Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (Bone Marrow Transplantation, (2020), 55, 6, (1114-1125), 10.1038/s41409-020-0803-y)

Articolo

Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (Bone Marrow Transplantation, (2018), 53, 5, (521-534), 10.1038/s41409-017-0062-8)

Articolo

Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes

Abstract

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

Articolo

Definition of GvHD-free, relapse-free survival for registry-based studies: An ALWP-EBMT analysis on patients with AML in remission

Articolo

Detection of host chimerism by patient-specific HLA alleles is a more sensitive marker than standard flow cytometry for relapse prediction of high-risk leukaemia after T-cell depleted stem cell transplantation

Articolo

Developing Centers Subcommittee: centre experience and results of allo-HSCT

Abstract

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

Articolo

Donor lymphocyte infusion from HLA-matched siblings outside of the context of a haematopoietic stem cell transplantation: a pilot study

Abstract

Double bone marrow harvest in paediatric donors for thalasemia siblings: safety, efficacy and ethical issues

Abstract

Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT

Abstract

Dual transgenesis of T-cells with a CD44v6 CAR and a suicide gene for the safe eradication of myeloid leukaemia and myeloma

Abstract

Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir

Articolo

Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse

Abstract

Early reconstitution of functional CMV immunity predicts a low risk for viral reactivation after HLA-haploidentical haematopoietic stem cell transplantation

Abstract

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall

Articolo

Early recovery of CMV-specific T cells after HLA-haploidentical HSCT with post-transplant cyclophosphamide is associated with a reduced risk of severe infections: a validation study

Abstract

Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia

Abstract

Editing central memory T-lymphocyte specificity for safe and effective adoptive immunotherapy of leukaemia

Abstract

Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies

Articolo

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

Articolo

Efficacy, Safety and Feasibility of Treatment of Chronic HCV Infection with Directly Acting Agents (DAAS) in HCT Recipients - EBMT Infectious Diseases Working Party Study

Abstract

Efficient differentiation of primary and secondary acute myeloid leukaemias into functionally competent leukaemic dendritic cells to improve graft-versus-leukemia effect

Abstract

Engraftment of CD34+ haplo-identical allogeneic cells after a non-TBI conditioning and ATG Fresenius: a single-centre experience in 30 patients

Abstract

Engraftment of pancreatic islets in bone marrow: preclinical evaluation and pilot clinical experience

Abstract

Epidemiology and biology of relapse after stem cell transplantation

Articolo

Erratum: BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT (Bone Marrow Transplantation (2014) 49 (1452) DOI:10.1038/bmt.2014.241)

Articolo

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia

Articolo

Escalating doses of donor lymphocytes to rescue from rejection following bone marrow transplantation for thalassaemia

Abstract

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Articolo

FETAL LIVER-TRANSPLANTATION - BIOLOGY AND CLINICAL-RESULTS

Articolo

FLOW CYTOMETRIC IMMUNOLOGICAL PROFILE OF HEALTHY SUBJECTS: HOW AGE AND SEX SHAPE OUR IMMUNE SYSTEM

Abstract

Factors influencing the occurrence of secondary malignancies in high-risk lymphoma patients following high-dose therapy and autograft

Abstract

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: A retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Articolo

Family haplo-identical allogeneic stem cell transplantation for acute leukaemias: a survey on 273 adults patients on behalf of the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Articolo

Feasibility and efficacy of allogeneic stem cell transplantation for refractory or relapsed myelodysplastic syndrome and secondary acute myeloid leukaemia: a single-centre experience

Articolo

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

Articolo

Foscarnet as single agent pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted allogeneic haematopoietic stem cell transplantation

Abstract

Foscarnet is an effective pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted haploidentical stem cell transplantation

Abstract

From the insertion nurse to the PICC team: an Italian experience

Abstract

Function of HSV-TK suicide gene transduced canine lymphocytes

Poster

Genomic and Transcriptional Profiling of Acute Myeloid Leukemia by Next-Generation Sequencing Unravels Patient-Specific Patterns of Post-Transplantation Relapse

Abstract

Graft Failure after Unmanipulated haplo-hsct with pt-cy in Patients with Acute Myeloid Leukemia in Complete Remission, on behalf of the ALWP-EBMT

Abstract

Graft-versus-Tumor effect (GvT) in advanced solid tumors following reduced-intensity stem cell allografting and Donor Lymphocyte Infusion (DLI)

Articolo

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

Articolo

Graft-versus-leukaemia with little graft-versus-host disease? A clinical phase I/II study using transfusion of transduced donor T-cells for donor leukocyte transfusion

Abstract

Graft-versus-tumor effect following reduced-intensity allogeneic stem cell transplantation in renal cell cancer

Articolo

Graft-versus-tumour effect following reduced-intensity allogeneic stem cell transplantation in renal cell cancer

Articolo

H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD

Abstract

HHV6 Specific T-cells are Predictor of Clinically Relevant HHV6 Infection after Allogeneic HSCT

Abstract

HLA Loss Leukemia Relapses after Partially-Mismatched Allogeneic HSCT: q Unique Model to Investigate Natural Killer Cell Dynamics

Abstract

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

Articolo

HLA-HAPLOIDENTICAL UMBILICAL-CORD BLOOD STEM-CELL TRANSPLANTATION IN A CHILD WITH ADVANCED LEUKEMIA - CLINICAL OUTCOME AND ANALYSIS OF HEMATOPOIETIC RECOVERY

Articolo

HLA-haploidentical transplantation with PTCY in AML patients with active disease at transplantation: Better survival with bm than with PBSC in patients > 55 years

Abstract

HSV-TK engineered donor lymphocytes provide early immune reconstitution after haplo-identical hemopoietic stem cell transplantation

Articolo

HUMAN HERPES VIRUS 6 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Abstract

Haematopoietic chimerism after T-cell depleted stem cell transplantation: early detection of host chimerism by patient-specific HLA alleles analysis is a sensitive marker for relapse of high-risk haematologic malignancies

Abstract

Haematopoietic stem cell transplantation in poor prognosis MDS and sAML: prolonged patients survival is achievable, but refining of infections management and reduction of treatment-related toxicities is required to improve patients outcome

Articolo

Haploidentical HSCT: a 15-year experience at San Raffaele.

Articolo

Haploidentical Stem Cell Transplantation In Very Poor Risk Cytogenetics Acute Myeloid Leukemia: results in 40 consecutive patients

Abstract

Haploidentical stem cell transplantation as immediate rescue from primary graft failure

Abstract

Haploidentical transplantation in patients with acquired aplastic anemia

Articolo

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Articolo

Hematopoietic Stem Cell Transplantation in Europe 2014: More than 40'000 transplants annually.

Articolo

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

Articolo

Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

Articolo

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Articolo

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT

Articolo

High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths

Articolo

High-dose lenograstim allows collection of autologous haematopoietic stem cells in elderly patients with acute myeloid leukaemia or myelodysplastic syndrome

Abstract

High-dose sequential chemoimmunotherapy supported by autologous stem cell transplantation in patients with systemic B-cell lymphoma and central nervous system involvement: interim analysis of a multicentre phase II Trial

Abstract

High-dose topotecan alone or in combination for treatment of advanced ovarian cancer: preliminary results

Articolo

High-sensitivity haematopoietic chimerism by qPCR for relapse prediction and specific identification of HLA loss leukaemic variants

Abstract

How to improve adoptive T-cell immunotherapy: the importance of be(ginn)ing naive

Contributo in Atti di convegno

Human Herpes Virus 6 Encephalitis: a major challenge after Haploidentical Hematopoietic Stem Cell Transplantation

Abstract

Human Herpesvirus-6 and GvHD after allogeneic haematopoietic stem cell transplantation

Abstract

Human herpes virus-6 reactivation after allogeneic haematopoietic stem cell transplantation

Abstract

INUTERO TRANSPLANTATION OF STEM-CELLS IN HUMANS - IMMUNOLOGICAL ASPECTS AND CLINICAL FOLLOW-UP OF PATIENTS

Articolo

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP

Articolo

Immuno responses of cord blood cells

Articolo

Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation

Abstract

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Articolo

Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria

Abstract

Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

Articolo

Impact of complete remission achievement on the survival of lymphoma patients undergoing high-dose sequential chemotherapy and autograft (HDS programme): a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) retrospective study on 1,266 patients

Articolo

Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Articolo

Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT

Articolo

Implementation of an alternative donor is a prerequisite for a good intention-to-treat performance in patients in need of allogeneic transplantation: analysis of 361 patients

Abstract

Implementing systematic search for alternative donor in patients in need of allogeneic transplantation: an intention-to-treat analysis of 282 patients at a BMT unit

Abstract

Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients

Abstract

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

Articolo

In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients

Contributo in Atti di convegno

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

Articolo

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Articolo

Intensified immunosuppression with ATG reduces graft failure without affecting immune reconstitution or infections in high-risk beta thalassaemia patients after HLA-identical sibling HSCT

Abstract

Intensified immunosuppression with ATG reduces graft rejection in class III beta thalasemia patients undergoing BMT from HLA-identical siblings after myeloablative conditioning

Abstract

Intravenous busulfan plus cyclophosphamide (Cyt) versus TBI plus Cy conditioning for allogeneic stem cell transplantation from matched unrelated donors. In adult patients with AML in first relapse: a survey from the ALWP of EBMT

Abstract

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

Articolo

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Articolo

Italian data on stem cell mobilisation with plerixafor in lymphoma and multiple myeloma patients: identification of prognostic factors

Abstract

Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells

Abstract

LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Abstract

LONG-TERM IMMUNOLOGICAL PROFILE AND T CELL DYNAMICS IN PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AND TK-CELLS FOR HEMATOLOGICAL MALIGNANCIES

Abstract

Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML

Articolo

Limited chronic graft-versus-host disease is associated with better survival after alternative donor transplants for haematological malignancies: a retrospective GITMO analysis

Abstract

Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT

Abstract

Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting

Articolo

Long-term immunological profile of patients treated with haploidentical HSCT and TK-cells to unravel the requirements of memory T cell persistence

Abstract

Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

Articolo

Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

Articolo

Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients

Abstract

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

Articolo

Loss of mismatched HLA as a mechanism of leukaemia immune escape in family haploidentical and unrelated haematopoietic stem cell transplantation

Abstract

Loss of mismatched HLA at leukaemia relapse after haematopoietic stem cell transplantation is significantly associated with clinical and immunogenetic hallmarks of donor-versus-host alloreactivity

Abstract

Low-dose antithymocyte globulin, post-transplant cyclophosphamide and sirolimus as graft-versus-host disease prophylaxis in unrelated donor transplants

Abstract

MISSING HLA C GROUP 1 LIGAND IN PATIENTS WITH AML AND MDS IS ASSOCIATED WITH REDUCED RISK OF RELAPSE AND IMPROVED SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND TREOSULFAN REDUCED TOXICITY CONDITIONING

Abstract

MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING

Abstract

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

Articolo

Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT

Articolo

Measurable Residual Disease (MRD) Testing for Acute Leukemia in EBMT Transplant Centers: A Survey on Behalf of The ALWP of the EBMT

Abstract

Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT

Articolo

Measured quality of life does not correlate with the clinical status of patients who receive an haematopoietic stem cell transplantation

Abstract

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?

Articolo

Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation?

Articolo

Moderate risk of secondary myelodysplastic syndrome/acute leukaemia occurrence following highdose sequential chemotherapy and autograft: a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey on 1266 lymphoma patients

Articolo

Modulated local treatment of GvHD skin lesions in patients after allogeneic stem cell transplantation contributes to rapid skin recover

Abstract

Molecular remission in relapsed/refractory chronic lymphocytic leukaemia and follicular lymphomas treated with RIC-allogeneic stem cell transplantation correlates with a better disease-free survival

Articolo

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Articolo

Monitoring of Willms' tumour gene 1 transcripts in AML and MDS patients can predict early relapse after allogeneic haematopoietic stem cell transplantation

Abstract

Morphologic and karyotypic analysis of bone marrow in 166 potential donors of hamatopoietic stem cells

Articolo

Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues

Articolo

Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients

Abstract

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

Articolo

NEW DEVELOPMENTS IN STEM-CELL TRANSPLANTATION WITH SPECIAL REFERENCE TO THE 1ST INUTERO TRANSPLANTS IN HUMANS

Articolo

NON-LINEAR CLONAL EVOLUTION OF LEUKEMIA DRIVEN BY THE SELECTIVE IMMUNE PRESSURE OF ALLOGENEIC HSCT

Abstract

NY-ESO-1 TCR single edited t cells to treat multiple myeloma without inducing GvHD

Abstract

Naive-derived memory stem T-cells: a novel promising platform for immune-gene therapy approaches

Abstract

Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients

Abstract

Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT

Articolo

Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance

Abstract

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)

Articolo

Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT

Articolo

Non-invasive ventilation in haematologic unit: single-centre experience in 24 patients

Articolo

Nucleophosmin 1 Mutation Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation to Predict Relapse and Guide Preemptive Therapy

Abstract

Observational retrospective study on the incidence of haemorrhagic cystitis and genital lesions in allogenic THSC patients treated with foscarnet

Abstract

Optimal thalasemia-free survival in patients Pesaro-class I and II coming from developing countries after haematopoietic stem cell transplantation from HLA identical sibling

Abstract

Optimal thalassaemia-free survival and minimal regimen-related toxicity in 50 consecutive high-risk beta thalassaemia paediatric patients using myeloablative therapy with intravenous busulphan

Abstract

Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

Articolo

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

Articolo

Palonosetron (Aloxi): a single-centre experience in the prevention of emesis in patients affected by haematological malignancies

Abstract

Pentraxin 3 as a Biomarker for Acute GvHD and Fungal Infections in Allogeneic Transplantation: Results of a Prospective Longitudinal Study in 73 Adult Recipients

Abstract

Perceived quality of life measures in haematopoietic stem cell transplantation clinical practice: results of prospective evaluation in 142 patients

Abstract

Pharmacokinetics of ATG-fresenius S in patients undergoing allogeneic stem cell transplantation: implications for adoptive immunotherapy

Abstract

Post Transplant Cyclophosphamide (PTCy) and Sirolimus for Haploidentical PBSC HSCT: favorable Immune Reconstitution and Low Rates of GvHD in 40 Patients

Abstract

Post-Transplant Cyclophosphamide Eliminates Mature Donor NK Cells Infused with the Graft, Dampening NK Cell Alloreactivity after Haploidentical HSCT

Abstract

Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

Articolo

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT

Articolo

Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients

Articolo

Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT

Articolo

Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy

Articolo

Pre-emptive treatment for CMV reactivation after allogeneic stem cell transplantation: a single-centre experience in 223 patients

Abstract

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Articolo

Pre-emptive treatment of acute graft-versus-host disease: A randomised multicentre trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Articolo

Pre-transplant FDG-PET predicts survival in lymphoma patients undergoing high-dose sequential chemotherapy followed by autologous stem cell transplantation

Articolo

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

Articolo

Prevention and treatment of relapse after stem cell transplantation by cellular therapies

Articolo

Prevention of GVHD in HLA-identical marrow grafts by removal of T cells with soybean agglutinin and SRBCs

Articolo

Primary tumour cells show specific susceptibility to KIR-incompatible NK cell-mediated lysis in an ex-vivo single cell cytotoxic assay by flow-cytometry

Articolo

Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT

Articolo

Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party

Articolo

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

Articolo

Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation

Articolo

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

Articolo

Quantitative PCR for Ins/Del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hamatopoietic stem cell transplantation

Abstract

Quantitative real-time PCR detection of Wilms's tumour gene (WT1) transcript in autologous peripheral blood stem cell products predict the risk of acute myeloid leukaemia relapse after autologous transplantation

Abstract

Quantitative real-time PCR evaluation of Wilms tumour gene transcript levels in autologous peripheral blood stem cell can predict the risk of acute myeloid leukaemia relapse after autologous transplantation

Abstract

RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA

Abstract

Rapamycin-based GvHD prophylaxis after T-cell replete unmanipulated haploidentical peripheral stem cell transplantation for advanced leukaemias: preliminary results of the TrRaMM study

Contributo in Atti di convegno

Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT

Abstract

Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data

Articolo

Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation

Articolo

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Articolo

Reduced and delayed incidence of human cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation in patients with refractory solid tumours

Articolo

Reduced-intensity allogeneic stem cell transplantation is an effective salvage strategy for relapsed/refractory peripheral T-cell non-Hodgkin lymphomas

Articolo

Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma

Articolo

Reduced-intensity conditioning followed by allogeneic transplantation has a better outcome than high-dose chemotherapy plus autografting in T-cell non-Hodgkin's lymphoma

Articolo

Reduced-intensity conditioning followed by allogeneic transplantation is an effective salvage treatment for patients with hematologic malignancies failing a previous autograft

Abstract

Reduced-intensity conditioning followed by allografting in patients with advanced haematological malignancies older than 60 years

Articolo

Reduced-intensity thiotepa based conditioning and rabbit anti-thymocyte globulin for alternative donor transplants: a prospective GITMO trial

Articolo

Relapse of AML after hematopoietic stem cell transplantation: Methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

Articolo

Retrospective comparison of transplant from matched unrelated donor or identical sibling in adult MDS: evidence for a graft-versus-myelodysplasia effect in unrelated donor transplant

Articolo

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: A new classification from the European Society for Blood and Marrow Transplantation

Articolo

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1

Articolo

Rituximab as pre-emptive therapy for EBV-reactivation following T-cell depleted allogeneic stem cell transplantation

Articolo

Rituximab markedly improves the efficacy of high-dose programmes with autograft for B-cell lymphoma: a multicentre GITIL survey on 957 patients

Articolo

Rituximab-bendamustine prior to donor lymphocyte infusion as salvage treatment in Hodgkin's disease patients relapsed post allogeneic stem cell transplantation

Abstract

Romiplostim for post-transplantation failure of platelet recovery

Abstract

SCID-HU MICE AS A MODEL TO STUDY TOLERANCE AFTER FETAL STEM-CELL TRANSPLANTATION

Articolo

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking.

Articolo

Second Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-based Conditioning Regimen for Acute Leukemia in Relapse

Abstract

Second allogeneic HSCT in patients with acute leukaemia relapsed after a first allogeneic transplantation: a retrospective GITMO study

Abstract

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

Articolo

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Articolo

Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft

Articolo

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: Analysis of risk factors and treatment outcomes

Articolo

Secondary solid tumors after allogeneic stem cell transplantation: active surveillance in long term follow-up

Abstract

Short-hairpin RNA interference with CD44v6 reveals a complex role in chemoresistance and leukemogenicity

Abstract

Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT

Articolo

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Articolo

Sorafenib as a safe bridge to immunotherapy in patients with FLT3-ITD relapsed AML after allogeneic HSCT: a single center experience in 14 patients

Abstract

Specific cell-therapy for reducing relapse risk after allo HCT

Abstract

Standardized care of long-term survivors after allogeneic stem cell transplantation: a cross-sectional 1-year evaluation in 249 adults

Abstract

Successful second sibling BMT following rejection in thalassemic patient

Abstract

Successful short nurse training project for the implementation of a new haematopoietic stem cell transplant programme in Syria

Abstract

Successful use of plerixafor in combination with G-CSF to achieve mega-doses of progenitors from healthy donors for haploidentical T-depleted stem cell transplantation

Abstract

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Articolo

T cell depleted marrow transplants for the treatment of leukemia

Articolo

T-CELL REPERTOIRE AND TOLERANCE AFTER FETAL STEM-CELL TRANSPLANTATION

Articolo

T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus

Abstract

T-cell immune reconstitution predicts the outcome of Human Herpes Virus 6 Infection in 54 Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Abstract

TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD

Abstract

THIOTEPA-CYCLOPHOSPHAMIDE HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AGGRESSIVE FORMS OF MULTIPLE SCLEROSIS: RESULTS IN 9 PATIENTS

Abstract

TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation

Abstract

TRACKING T CELL DYNAMICS IN THE FIRST MONTH AFTER ALLOGENEIC HSCT OFFERS A UNIQUE OPPORTUNITY TO UNVEIL THE MECHANISM OF MEMORY STEM T CELL FORMATION IN HUMANS

Abstract

Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)

Articolo

Targeting Naive CD8+T-cells allows the generation of gene-modified lymphocytes with high proliferative potential and early differentiation phenotype

Poster

Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients

Abstract

Targeting of a therapeutic suicide gene to human alloreactive memory T-cells with stem-cell features requires IL-7 and IL-15

Abstract

Targeting of myeloid leukaemia stem cells through genetic redirection of T-cells against CD44v6

Abstract

Tear film osmolarity in chronic ocular GvHD patients

Abstract

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

Articolo

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

Articolo

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML

Articolo

The fate of gene modified T-cells can be followed in 2 patients after PBSCT

Articolo

The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT

Articolo

Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in aggressive forms of multiple sclerosis: results in 9 patients

Abstract

Thymic renewal in adult leukaemia patients after haplodentical stem cell transplantation and infusion of suicide gene-modified donor T-cells

Abstract

Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009

Poster

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

Articolo

Treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with high-dose immunosuppressive therapy (HDIT) using cyclophosphamide with autologous hematopoietic stem cell rescue

Articolo

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

Articolo

Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT

Articolo

Treosulfan-based conditioning regimen for allo-SCT in 283 patients: co-morbidity index and disease status are predictors of outcomes

Contributo in Atti di convegno

Treosulfan-fludarabine-ATG-F based reduced-toxicity conditioning regimen: multicentre "Allo-Treo" study, results in 183 patients with haematological malignancies

Abstract

Treosulfan-fludarabine-cytarabine myeloablative conditioning for autologous stem cell transplantation in elderly patients with acute myeloid leukaemia and myelodysplastic syndrome in first complete remission

Abstract

Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease

Articolo

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

Articolo

Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT

Articolo

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

Articolo

Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy

Articolo

Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT

Articolo

Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation

Articolo

Voriconazole prophylaxis in 120 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation

Abstract

Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Articolo

No Results Found